Manufacturing

Articles

Products on display include the newest addition to the Mobius line of single-use bioreactors; Cellvento CHO cell culture media for optimized production of specific cell lines; and new high-volume AFS water purification systems.

A Glance of Merck Millipore’s New Solutions for Increased Efficiency

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Biopharma companies on both sides of the Atlantic ship more of their assay testing to outside service providers.

Another In-House Operation Gets Outsourced

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Catalent announced that it would partner with Mitsubishi Gas Chemical Company, and its subsidiary MGC Pharma, to promote GPEx technology, a high-titer vector for stable mammalian cell lines.

Catalent and MGC Pharma Partner for Production of Cell Lines

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

CMC Biologics and OnoSynergy form an agreement from cell-line development.

CMC Biologics and OncoSynergy Form Pact

BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.

Lonza, BioWa Sign Licensing Agreement

Facility will use mammalian cell-culture technology and be ready for operations by 2016.

Boehringer Ingelheim Plans Biopharmaceuticals Facility in China

Kate Achtien in an R&D scientist at SAFC. kate.achtien@SAFC.com

Applications of ZFN technology in biopharmaceutical cell-line engineering.

ZFN Technology Advances Biopharmaceutical Manufacturing

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.

Gauging Biopharm Outsourcing

Amy Ritter was Scientific Editor, BioPharm International.

More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.

Manufacturing, Cell-Line Selection